| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/05/1999 | WO1999038868A1 Azolo triazines and pyrimidines |
| 08/05/1999 | WO1999038850A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 08/05/1999 | WO1999038845A1 Ppar-gamma modulators |
| 08/05/1999 | WO1999038518A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation |
| 08/05/1999 | WO1999038504A1 Pharmaceutical uses of optically pure (-)-bupropion |
| 08/05/1999 | WO1999038502A1 Pharmaceutical uses of optically pure (+)-bupropion |
| 08/05/1999 | WO1999038501A2 Method of regulating glucose metabolism, and reagents related thereto |
| 08/05/1999 | WO1999038498A1 Method for treating alzheimer's disease |
| 08/05/1999 | WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51 |
| 08/05/1999 | WO1999022721A3 Unsubstituted polydiallylamine for treating hypercholesterolemia |
| 08/05/1999 | WO1999021538A3 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye |
| 08/05/1999 | CA2819705A1 Method of regulating glucose metabolism, and reagents related thereto |
| 08/05/1999 | CA2755452A1 Method of regulating glucose metabolism, and reagents related thereto |
| 08/05/1999 | CA2335037A1 Aqueous compositions comprising complexing agents and uses thereof |
| 08/05/1999 | CA2319195A1 Method of regulating glucose metabolism, and reagents related thereto |
| 08/05/1999 | CA2318960A1 Pharmaceutical uses of optically pure (+)-bupropion |
| 08/05/1999 | CA2318920A1 Pharmaceutical uses of optically pure (-)-bupropion |
| 08/05/1999 | CA2318443A1 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation |
| 08/04/1999 | EP0932672A1 Human sulfonylurea receptor surh |
| 08/04/1999 | EP0932410A1 Mistletoe (viscum) extracts |
| 08/04/1999 | EP0932395A1 Methods and compositions employing red yeast fermentation products |
| 08/04/1999 | EP0752985B1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 08/04/1999 | CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 08/04/1999 | CN1225082A Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same |
| 08/04/1999 | CN1224715A Cycloalkano-indote and againdole derivatives, process for their preparation and pharmaceutical composition containing the same |
| 08/03/1999 | US5932765 Nitromethyl ketones, process for preparing them and compositions containing them |
| 08/03/1999 | US5932737 Peptide compounds for treatment of no-mediated diseases |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932595 Antiarthritic agent; multiple sclerosis; osteoporosis; respiratory system disorders; skin disorders; antiulcer agent |
| 08/03/1999 | US5932593 Antiserotonin agent |
| 08/03/1999 | US5932587 Heterocyclic-fused pyridines |
| 08/03/1999 | US5932581 Administering sorbitol dehydrogenase inhibitor |
| 08/03/1999 | US5932565 Vitamin D analogues |
| 08/03/1999 | US5932562 Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same |
| 08/03/1999 | US5932549 Treating alzheimer*s disease, septic shock, acute myelogenous leukemia, stroke, and inflammatory bowel disease |
| 08/03/1999 | CA2182101C Neuroprotective compounds |
| 07/29/1999 | WO1999037682A2 Antibodies against human il-12 |
| 07/29/1999 | WO1999037651A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037639A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
| 07/29/1999 | WO1999037637A1 Benzamide derivatives as vasopressin antagonists |
| 07/29/1999 | WO1999037623A2 Sulphonamide derivatives for treatment of cns disorders |
| 07/29/1999 | WO1999037622A1 Nitrogenous heterocyclic derivatives and medicine thereof |
| 07/29/1999 | WO1999037619A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/29/1999 | WO1999037604A2 Dialkyl ureas as calcitonin mimetics |
| 07/29/1999 | WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use |
| 07/29/1999 | WO1999037309A1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation |
| 07/29/1999 | WO1999037305A1 Pharmaceutically active morpholinol |
| 07/29/1999 | WO1999037294A2 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/29/1999 | WO1999037167A2 Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby |
| 07/29/1999 | WO1999021617A3 Allosteric adenosine receptor modulators |
| 07/29/1999 | WO1999020755A3 Novel cytokine receptors |
| 07/29/1999 | WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 07/29/1999 | CA2319199A1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation |
| 07/29/1999 | CA2319158A1 Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby |
| 07/29/1999 | CA2319131A1 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/29/1999 | CA2319077A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318268A1 Pharmaceutically active morpholinol |
| 07/29/1999 | CA2318088A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2317740A1 Sulphonamide derivatives for treatment of cns disorders |
| 07/29/1999 | CA2284864A1 Dialkyl ureas as calcitonin mimetics |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0930889A1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 07/28/1999 | EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 07/28/1999 | CN1224424A Azolobenzazepine derivs. as neurologically active agents |
| 07/28/1999 | CN1224416A Creatine pyruvates and method for their production |
| 07/28/1999 | CN1224352A Anticonvulsant sulfamate derivs. useful in treating obesity |
| 07/28/1999 | CN1224011A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/27/1999 | US5929092 Lipophilic benzothiophenes for treating estrogen deficiency |
| 07/27/1999 | US5929075 Apolipoprotein-B synthesis inhibitors |
| 07/27/1999 | US5929066 Administering to a patient suffering from non-insulin depentednt (type ii) diabetes and effective amount of synthetic chromic tripicolinate and biotine |
| 07/27/1999 | US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 07/27/1999 | US5929056 Accesible from readily available starting materials to be used for wound healing and in cosmetics |
| 07/27/1999 | US5929055 Tetracycline |
| 07/27/1999 | US5928670 Method of inhibiting aldose reductase in vivo with intrinsic inhibitors of aldose reductase |
| 07/27/1999 | CA2170700C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 07/27/1999 | CA2016504C Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
| 07/22/1999 | WO1999036436A1 FATTY ACID SYNTHASE mRNA BINDING PROTEIN |
| 07/22/1999 | WO1999036396A1 Triazepinones, process for their preparation and their therapeutic application |
| 07/22/1999 | WO1999036393A1 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | WO1999036077A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | WO1999036075A1 Oral oil sorbing composition |
| 07/22/1999 | WO1999036060A1 Oral liquid compositions |
| 07/22/1999 | WO1999017712A3 Tightening and/or reducing the size of body parts containing fat cells |
| 07/22/1999 | CA2318525A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318236A1 Oral oil sorbing composition |
| 07/22/1999 | CA2317813A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | CA2315299A1 Fatty acid synthase mrna binding protein |
| 07/21/1999 | EP0930299A1 Propionic acid derivatives and applications thereof |
| 07/21/1999 | EP0930019A2 Composition for treating obesity and foods and drinks containing the same |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929576A1 Glp-2 derivatives |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929520A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 07/21/1999 | EP0929232A1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 07/21/1999 | EP0765327B1 Pyrazolo and pyrrolopyridines |
| 07/21/1999 | EP0745092B1 Peptide inhibitors of urokinase receptor activity |